Testing effectiveness (Phase 2)Study completedNCT00111085
What this trial is testing
Clazosentan in Preventing the Occurrence of Cerebral Vasospasm Following an Aneurysmal Subarachnoid Hemorrhage (aSAH)
Who this might be right for
Aneurysmal Subarachnoid Hemorrhage
Idorsia Pharmaceuticals Ltd. 413